Device shows potential in preventing stroke by blocking clots

10/3/2013 | Charleston Regional Business Journal (S.C.)

PMG Research is conducting a clinical trial comparing the effectiveness of St. Jude Medical's Amplatzer cardiac plug, an anti-clotting device, to anticoagulant therapy. The device is inserted into a patient's leg via catheter and blocks part of the heart to keep clots from flowing into the bloodstream. Researcher Dr. Matthew O'Steen said the Amplatzer shows promise in stroke prevention.

View Full Article in:

Charleston Regional Business Journal (S.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide